申请人:Hoffmann-La Roche Inc.
公开号:US08901124B2
公开(公告)日:2014-12-02
The present invention relates to the use of novel triazolopyridine derivatives of formula I:
wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用以下式I的新型三唑并[3,4-b]吡啶衍生物,其中所有变量取代基的定义如本文所述,这些衍生物为SYK抑制剂,可用于治疗自身免疫和炎症性疾病。